این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Middle East Journal of Digestive Diseases، جلد ۱۶، شماره ۲، صفحات ۱۰۹-۱۱۳
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Incidence of Elevated Liver Enzyme Levels in Patients Receiving Remdesivir and Its Effective Factors
چکیده انگلیسی مقاله Background: Emergency use of remdesivir was approved for COVID-19 in some countries. Based on the promising results of remdesivir, the most common side effects were nausea, worsening respiratory failure, increased alanine aminotransferase levels, and constipation. The aim of this study was to determine the incidence of elevated liver enzymes in patients with COVID-19 receiving remdesivir. Methods : In this retrospective study, information was collected from patients' files. The study population included patients with moderate to severe COVID-19 who were admitted to Rouhani Babol Hospital. For daily patient selection, the list of patients was extracted from the system, and based on the census, the patient file was selected. Data were analyzed using Stata 16. Results : 620 patients suffering from moderate to severe COVID-19 were included in this study, 43% of whom were men. Of these patients, 120 were selected as the control group who did not receive remdesivir. The increase in liver enzymes in patients receiving remdesivir compared with the control, for alanine transaminase (ALT) and aspartate transaminase (AST), respectively, was 6.20 and 3.64 times, but it was not statistically significant for ALP. Also, the increase in bilirubin levels in patients receiving remdesivir was not statistically significant. Conclusion : The recipients of remdesivir had high liver enzymes, which is one of the possible side effects of this drug. The intensity of the enzymes was mild and moderate, and they were not dangerous to the health of any of the consumers. Deaths in patients with COVID-19 were not due to drug-induced liver complications but to other factors such as disease-related complications.
کلیدواژه‌های انگلیسی مقاله Remdesivir, COVID-19, Aspartate transaminase, Alanine transaminase, Mortality, Adverse effects
نویسندگان مقاله | Fatere Seyedalipour
Faculty of pharmacy, Ayatollah Amoli branch, Islamic Azad university, Amol, Iran.


| Shabnam Alipour
Department of Internal Medicine, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.


| Hamed Mehdinezhad
School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.


| Rahim Akrami
Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.


| Hoda Shirafkan


نشانی اینترنتی http://mejdd.org/index.php/mejdd/article/view/2808
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات